Shushang Chen

491 total citations
16 papers, 360 citations indexed

About

Shushang Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Shushang Chen has authored 16 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Shushang Chen's work include Kidney Stones and Urolithiasis Treatments (4 papers), Pelvic floor disorders treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Shushang Chen is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (4 papers), Pelvic floor disorders treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Shushang Chen collaborates with scholars based in China, Taiwan and United States. Shushang Chen's co-authors include Ming Jen Tan, Shunliang Yang, Lianming Liao, Meijing Wu, Weizhen Wu, Jun Lü, Huiyue Dong, Weizhen Wu, Hu Zhao and Ling Zhu and has published in prestigious journals such as The Journal of Urology, European Urology and Journal of Cellular Physiology.

In The Last Decade

Shushang Chen

15 papers receiving 359 citations

Peers

Shushang Chen
Trevor Dorkin United Kingdom
Shushang Chen
Citations per year, relative to Shushang Chen Shushang Chen (= 1×) peers Trevor Dorkin

Countries citing papers authored by Shushang Chen

Since Specialization
Citations

This map shows the geographic impact of Shushang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shushang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shushang Chen more than expected).

Fields of papers citing papers by Shushang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shushang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shushang Chen. The network helps show where Shushang Chen may publish in the future.

Co-authorship network of co-authors of Shushang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shushang Chen. A scholar is included among the top collaborators of Shushang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shushang Chen. Shushang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Shushang, Ronghui Lin, Junjie Wei, et al.. (2024). The inhibition effect of psoralen on prostate cancer PC3 cells via down-regulation of long non-coding RNA ENST00000510619. Translational Andrology and Urology. 13(10). 2294–2306.
2.
Chen, Shushang, et al.. (2023). Comparison of RLP and PCNL for large pelvis calculi with CKD. Minimally Invasive Therapy & Allied Technologies. 33(1). 51–57. 1 indexed citations
3.
Chen, Shushang, et al.. (2023). Laparoscopic prostatectomy with complete urethral reconstruction for sexually active BPH patients. Minimally Invasive Therapy & Allied Technologies. 33(1). 29–34. 1 indexed citations
4.
Chen, Shushang, et al.. (2022). Risk factors for renal allograft survival with China novel donation category: Donation after brain death followed by cardiac arrest. Transplant Immunology. 72. 101591–101591. 4 indexed citations
5.
Dong, Huiyue, Ling Zhu, Jingjing Sun, et al.. (2021). Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma. Journal of Cancer. 12(20). 6242–6253. 13 indexed citations
6.
Lü, Jun, Zhan Chen, Hu Zhao, et al.. (2020). ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma. Journal of Translational Medicine. 18(1). 101–101. 48 indexed citations
7.
Zhao, Hu, Junqiu Chen, Jin Chen, et al.. (2019). miR‐192/215‐5p act as tumor suppressors and link Crohn's disease and colorectal cancer by targeting common metabolic pathways: An integrated informatics analysis and experimental study. Journal of Cellular Physiology. 234(11). 21060–21075. 14 indexed citations
8.
Lü, Jun, Ling Zhu, Qiang Cui, et al.. (2018). Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965. EBioMedicine. 34. 85–93. 68 indexed citations
11.
Zhou, Hao, Shushang Chen, Weidong Chen, et al.. (2012). Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation. Clinical and Experimental Nephrology. 17(2). 304–309. 4 indexed citations
12.
Chen, Shushang, Shunliang Yang, Meijing Wu, et al.. (2012). Electrosurgical Enucleation Versus Bipolar Transurethral Resection for Prostates Larger than 70 ml: A Prospective, Randomized Trial with 5-Year Followup. The Journal of Urology. 189(4). 1427–1431. 78 indexed citations
14.
15.
Chen, Shushang, Xiaofeng Gao, Yinghao Sun, et al.. (2009). Analysis of HK-2 cells exposed to oxalate and calcium oxalate crystals: proteomic insights into the molecular mechanisms of renal injury and stone formation. Urological Research. 38(1). 7–15. 22 indexed citations
16.
Sun, Yinghao, et al.. (2009). 70 W Holmium:Yttrium-Aluminum-Garnet Laser in Percutaneous Nephrolithotomy for Staghorn Calculi. Journal of Endourology. 23(10). 1687–1691. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026